| Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials Chang Lancet Oncology 16, 630-7, 2015 | 1087 | 2015 |
| Prophylactic cranial irradiation in extensive small-cell lung cancer B Slotman, C Faivre-Finn, G Kramer, E Rankin, M Snee, M Hatton, ... New England Journal of Medicine 357 (7), 664-672, 2007 | 1013 | 2007 |
| Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non–small-cell lung cancer FJ Lagerwaard, CJA Haasbeek, EF Smit, BJ Slotman, S Senan International Journal of Radiation Oncology* Biology* Physics 70 (3), 685-692, 2008 | 558 | 2008 |
| Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study WFAR Verbakel, JP Cuijpers, D Hoffmans, M Bieker, BJ Slotman, ... International Journal of Radiation Oncology* Biology* Physics 74 (1), 252-259, 2009 | 511 | 2009 |
| Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up J Vansteenkiste, D De Ruysscher, WEE Eberhardt, E Lim, S Senan, ... Annals of oncology 24, vi89-vi98, 2013 | 492 | 2013 |
| Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non–small-cell lung cancer: a population-based time-trend analysis D Palma, O Visser, FJ Lagerwaard, J Belderbos, BJ Slotman, S Senan Journal of clinical oncology 28 (35), 5153-5159, 2010 | 434 | 2010 |
| Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis DA Palma, S Senan, K Tsujino, RB Barriger, R Rengan, M Moreno, ... International Journal of Radiation Oncology* Biology* Physics 85 (2), 444-450, 2013 | 429 | 2013 |
| Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis S Senthi, FJ Lagerwaard, CJA Haasbeek, BJ Slotman, S Senan The lancet oncology 13 (8), 802-809, 2012 | 401 | 2012 |
| Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer FJ Lagerwaard, NE Verstegen, CJA Haasbeek, BJ Slotman, MA Paul, ... International Journal of Radiation Oncology* Biology* Physics 83 (1), 348-353, 2012 | 353 | 2012 |
| European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer D De Ruysscher, C Faivre-Finn, U Nestle, CW Hurkmans, C Le Péchoux, ... Journal of clinical oncology 28 (36), 5301-5310, 2010 | 347* | 2010 |
| Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer RWM Underberg, FJ Lagerwaard, BJ Slotman, JP Cuijpers, S Senan International Journal of Radiation Oncology* Biology* Physics 63 (1), 253-260, 2005 | 343 | 2005 |
| Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and … C Le Péchoux, A Dunant, S Senan, A Wolfson, E Quoix, C Faivre-Finn, ... The lancet oncology 10 (5), 467-474, 2009 | 338 | 2009 |
| Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer RWM Underberg, FJ Lagerwaard, JP Cuijpers, BJ Slotman, ... International Journal of Radiation Oncology* Biology* Physics 60 (4), 1283-1290, 2004 | 328 | 2004 |
| Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a … NE Verstegen, JWA Oosterhuis, DA Palma, G Rodrigues, FJ Lagerwaard, ... Annals of oncology 24 (6), 1543-1548, 2013 | 276 | 2013 |
| Multiple “slow” CT scans for incorporating lung tumor mobility in radiotheraphy planning FJ Lagerwaard, JRVS de Koste, MRJ Nijssen-Visser, ... International Journal of Radiation Oncology* Biology* Physics 51 (4), 932-937, 2001 | 260 | 2001 |
| Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms—results of an … BJ Slotman, ME Mauer, A Bottomley, C Faivre-Finn, GWPM Kramer, ... Journal of clinical oncology 27 (1), 78, 2009 | 242 | 2009 |
| Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus T Ritter, DJ Quint, S Senan, LE Gaspar, RU Komaki, CW Hurkmans, ... International Journal of Radiation Oncology* Biology* Physics 81 (5), 1442-1457, 2011 | 234 | 2011 |
| Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer CJA Haasbeek, FJ Lagerwaard, BJ Slotman, S Senan Journal of Thoracic Oncology 6 (12), 2036-2043, 2011 | 231 | 2011 |
| Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised … CW Hurkmans, JP Cuijpers, FJ Lagerwaard, J Widder, UA van der Heide, ... Radiation Oncology 4 (1), 1-14, 2009 | 230 | 2009 |
| Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer S Senan, D De Ruysscher, P Giraud, R Mirimanoff, V Budach Radiotherapy and oncology 71 (2), 139-146, 2004 | 230 | 2004 |
